These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 27829767)

  • 1. Correlation of serum levo-fucose levels as a biomarker with tumor node metastasis staging in oral cancer patients.
    Manchil PR; Joy ET; Kiran MS; Sherubin JE; Khan MF; Aravind BS
    J Pharm Bioallied Sci; 2016 Oct; 8(Suppl 1):S147-S150. PubMed ID: 27829767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative evaluation of serum fucose in oral squamous cell carcinoma patients.
    Parwani RN; Parwani SR
    J Cancer Res Ther; 2011; 7(2):143-7. PubMed ID: 21768700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Serum Fucose Levels in Leukoplakia and Oral Cancer Patients.
    Rai NP; Anekar J; Shivaraja Shankara YM; Divakar DD; Al Kheraif AA; Ramakrishnaiah R; Sebastian R; Raj AC; Al-Hazmi A; Mustafa SM
    Asian Pac J Cancer Prev; 2015; 16(17):7497-500. PubMed ID: 26625751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Serum Fucose Level among Oral Squamous Cell Carcinoma Patients: A Case-Control Study.
    Ashem A; Mehta DN; Singh DN; Singh KC; Anupriya C; Devi AN
    J Pharm Bioallied Sci; 2023 Jul; 15(Suppl 2):S878-S880. PubMed ID: 37694091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up regulation of serum L fucose glycoprotein as a diagnostic biomarker for dysplasia in oral sub mucous fibrosis patients.
    Vaddamanu SK; Saini RS; Veerabasavaiah BT; Alhamoudi FH; Ali F Alshadidi A; Lo Giudice A; Cicciù M; Minervini G
    Heliyon; 2024 Jan; 10(2):e24211. PubMed ID: 38312635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum big endothelin-1 as a biomarker in oral squamous cell carcinoma patients: an analytical study.
    Mankapure PK; Barpande SR; Bhavthankar JD; Mandale M
    J Appl Oral Sci; 2015 Oct; 23(5):491-6. PubMed ID: 26537720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of Serum L-fucose Glycoprotein as Cancer Biomarker in Head and Neck Malignancies without Distant Metastasis.
    Shetty RK; Bhandary SK; Kali A
    J Clin Diagn Res; 2013 Dec; 7(12):2818-20. PubMed ID: 24551646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum fucose level in oral cancer, leukoplakia, and oral sub mucous fibrosis: A biochemical study.
    Kumar S; Suhag A; Kolay SK; Kumar P; Narwal A; Srinivas K; Haideri S
    J Family Med Prim Care; 2019 Jul; 8(7):2414-2419. PubMed ID: 31463268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of Serum Butyryl Cholinesterase in Patients with Oral Squamous Cell Carcinoma: A Cross-Sectional Study.
    Nair KK; Pramod GV; Chaudhuri K; Ashok L
    J Clin Diagn Res; 2017 Jul; 11(7):ZC59-ZC62. PubMed ID: 28893045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fucose: A biomarker in grading of oral cancer.
    Kumar S; Saxena M; Srinivas K; Singh VK
    Natl J Maxillofac Surg; 2015; 6(2):176-9. PubMed ID: 27390492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of serum sialic acid, fucose levels and their ratio in oral squamous cell carcinoma.
    Chinnannavar SN; Ashok L; Vidya KC; Setty SM; Narasimha GE; Garg R
    J Int Soc Prev Community Dent; 2015; 5(6):446-50. PubMed ID: 26759796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Concordance Between Clinical and Pathological Tumor Staging of Oral Squamous Cell Carcinoma: An Institutional Study.
    S D; Ramalingam K; Ramani P; Krishnan M
    Cureus; 2024 Jun; 16(6):e61584. PubMed ID: 38962622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of Clinical and Pathological TNM Staging With Histopathological Grading in Oral Squamous Cell Carcinoma.
    Tehzeeb H; Hande A; Patil S; Sonone A; Pakhale A; Chavhan A
    Cureus; 2024 May; 16(5):e60912. PubMed ID: 38910661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of serum pyruvic acid levels in oral squamous cell carcinoma.
    Guduguntla P; Guttikonda VR
    J Oral Maxillofac Pathol; 2020; 24(3):585. PubMed ID: 33967514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of serum L-fucose in brain tumor cases.
    Manjula S; Monteiro F; Rao Aroor A; Rao S; Annaswamy R; Rao A
    Ann Indian Acad Neurol; 2010 Jan; 13(1):33-6. PubMed ID: 20436744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Utility of Serum Homocysteine and Folate as Tumor Markers in Oral Squamous Cell Carcinoma - A Cross-Sectional Study.
    Erugula SR; Kandukuri MK; Danappanavar PM; Ealla KK; Velidandla S; Manikya S
    J Clin Diagn Res; 2016 Oct; 10(10):ZC24-ZC28. PubMed ID: 27891452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated tissue nitric oxide in oral squamous cell carcinoma.
    Sangle VA; Chaware SJ; Kulkarni MA; Ingle YC; Singh P; Pooja VK
    J Oral Maxillofac Pathol; 2018; 22(1):35-39. PubMed ID: 29731554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elucidating the immunohistochemistry of Nanog: A transcription marker in the oral squamous cell carcinoma with emphasis on its origin as embryonic stem cell.
    Afroze SN; Rao GV; Suri S
    J Oral Maxillofac Pathol; 2022; 26(4):476-482. PubMed ID: 37082043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine Deaminase - a Novel Diagnostic and Prognostic Biomarker for Oral Squamous Cell Carcinoma.
    Kelgandre DC; Pathak J; Patel S; Ingale P; Swain N
    Asian Pac J Cancer Prev; 2016; 17(4):1865-8. PubMed ID: 27221867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of serum sialic acid in oral submucous fibrosis and oral squamous cell carcinoma.
    Chittemsetti S; Manchikatla PK; Guttikonda V
    J Oral Maxillofac Pathol; 2019; 23(1):156. PubMed ID: 31110436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.